|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
3045072 |
003 |
ICU |
005 |
20060630124200.0 |
008 |
980218s1997 nyua b 101 0 eng c |
010 |
|
|
|a 98012983
|
020 |
|
|
|a 0306458187
|
035 |
|
|
|a (OCoLC)38528411
|
040 |
|
|
|a DNLM/DLC
|c DLC
|d NLM
|d GZM
|d C#P
|d AGL
|d OrLoB-B
|d OCoLC
|
049 |
|
|
|a CGUA
|
050 |
0 |
0 |
|a QR189
|b .V237 1997
|
060 |
1 |
0 |
|a QW 805
|b V11587 1997
|
069 |
0 |
|
|a 9803766
|
070 |
0 |
|
|a QH301.N32
|b v.293
|
072 |
|
0 |
|a X300
|a X380
|
082 |
0 |
0 |
|a 615/.372
|2 21
|
245 |
0 |
0 |
|a Vaccine design :
|b the role of cytokine networks /
|c edited by Gregory Gregoriadis and Brenda McCormack and Anthony C. Allison.
|
260 |
|
|
|a New York :
|b Plenum Press,
|c c1997.
|
300 |
|
|
|a viii, 209 p. :
|b ill. ;
|c 26 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
440 |
|
0 |
|a NATO ASI series.
|n Series A,
|p Life sciences
|v v. 293
|
500 |
|
|
|a "Proceedings of a NATO Advanced Study Institute on Vaccine Design: The Role of Cytokine Networks, held June 24-July 5, 1996, in Cape Sounion, Greece"--T.p. verso.
|
500 |
|
|
|a "Published in cooperation with NATO Scientific Affairs Division."
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|t The Role of Cytokines in the Action of Immunological Adjuvants /
|r Anthony C. Allison --
|t The Role of Tumour Necrosis Factor in Lymphoid Tissue Formation and Function /
|r Manolis Pasparakis, Eleni Douni and Lena Alexopoulou [et al.] --
|t Dendritic Cells and Cytokines /
|r Jonathan M. Austyn --
|t Control of HIV Entry and Transcription, as a Possible Mechanism of the Antiviral Effects of T Lymphocytes in HIV Infection /
|r J.-L. Virelizier, A. Amara and E. Oberlin [et al.] --
|t Development of an Influenza-Iscom Vaccine /
|r John Cox, Alan Coulter and Rod Macfarlan [et al.] --
|t Development of Parainfluenza Virus and Respiratory Syncytial Virus Subunit Vaccines /
|r M. Ewasyshyn, G. Cates and G. Jackson [et al.] --
|t Mucosal Vaccines: Perspectives on the Development of Anti-H.pylori Vaccines /
|r Paolo Ghiara --
|t A Single Treatment with Adjuvant Stimulates Th1-like Cytokines and Downregulates Th2-Mediated Primary and Secondary Allergic Responses /
|r Dorothy E. Scott and Basil Golding --
|t Induction of IL-12 Secretion and Enhanced Surface Expression of B7.1/B7.2 and ICAM-1 in Human Monocytes Activated by the Vaccine Carrier Brucella abortus: Correlation with in Vivo Generation of Cellular Immune Responses /
|r H. Golding, M. B. Zaitseva and C. K. Lapham [et al.] --
|t The Potential Use of Different Vaccination Protocols to Tailor Cytokine Profiles /
|r Emmanuel Comoy, Andre Capron and Georges Thyphronitis --
|t Modulation of Cytokine Responses by Iscoms and Iscom-Matrix /
|r Maria Villacres-Eriksson, Shahriar Behboudi and Karin Lovgren-Bengtsson [et al.] --
|t Vaccines and Vaccine Delivery Systems: Experience with HSV, Influenza and Mucosal Routes of Immunisation /
|r R. Jennings, D. Ni Challanain and H. O. Ghazi [et al.] --
|t Active Immunotherapy for Solid Tumours /
|r A. Maraveyas and A. G. Dalgleish --
|t ISCOMS as Mucosal Vaccine Vectors /
|r Allan McI. Mowat, Kevin J. Maloy and Rosemary E. Smith [et al.] --
|t Adjuvant Directed Immune Specificity at the Epitope Level: Implications for Vaccine Development. A Model Study Using Semliki Forest Virus Infection of Mice /
|r H. Snippe, I. M. Fernandez and C. A. Kraaijeveld --
|t Interleukin 1 and Its Synthetic Peptide 163-171 as Vaccine Adjuvants /
|r Aldo Tagliabue and Diana Boraschi --
|t The Immunological Co-Adjuvant Action of Liposomal Interleukin-15 /
|r Mayda Gursel and Gregory Gregoriadis --
|t Protection against Tuberculosis by Plasmid DNA /
|r R. E. Tascon, M. J. Colston and E. Stavropoulos [et al.] --
|t From Scientific Discovery to Clinical Trial: Overcoming the Regulatory Hurdles - A Guide for Academic Researchers /
|r Jillian K. Bennet.
|
650 |
|
0 |
|a Vaccines
|v Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2010117638
|
650 |
|
0 |
|a Cytokines
|v Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2009122738
|
650 |
|
0 |
|a Immunological adjuvants
|v Congresses.
|
650 |
1 |
2 |
|a Vaccines
|v congresses.
|
650 |
1 |
2 |
|a Drug Design
|v congresses.
|
650 |
2 |
2 |
|a Adjuvants, Immunologic
|v congresses.
|
650 |
2 |
2 |
|a Cytokines
|x pharmacokinetics
|v congresses.
|
650 |
2 |
2 |
|a Cytokines
|x physiology
|v congresses.
|
650 |
|
7 |
|a Cytokines.
|2 fast
|0 http://id.worldcat.org/fast/fst00886268
|
650 |
|
7 |
|a Immunological adjuvants.
|2 fast
|0 http://id.worldcat.org/fast/fst00967992
|
650 |
|
7 |
|a Vaccines.
|2 fast
|0 http://id.worldcat.org/fast/fst01163573
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 http://id.worldcat.org/fast/fst01423772
|
700 |
1 |
|
|a Gregoriadis, Gregory.
|0 http://id.loc.gov/authorities/names/n79077632
|1 http://viaf.org/viaf/44416002
|
700 |
1 |
|
|a McCormack, Brenda.
|0 http://id.loc.gov/authorities/names/n94803400
|1 http://viaf.org/viaf/43541284
|
700 |
1 |
|
|a Allison, Anthony C.
|q (Anthony Clifford),
|d 1925-
|0 http://id.loc.gov/authorities/names/n50021036
|1 http://viaf.org/viaf/74001223
|
710 |
2 |
|
|a North Atlantic Treaty Organization.
|b Scientific Affairs Division.
|0 http://id.loc.gov/authorities/names/n79142766
|1 http://viaf.org/viaf/141814054
|
711 |
2 |
|
|a NATO Advanced Study Institute on Vaccine Design--the Role of Cytokine Networks
|d (1996 :
|c Akra Sounion, Greece)
|0 http://id.loc.gov/authorities/names/n98800679
|1 http://viaf.org/viaf/130201385
|
901 |
|
|
|a ToCBNA
|
903 |
|
|
|a HeVa
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 1c8bda0d-18f0-5b4a-9d47-034a2ee38037
|s 40e38ae7-12b9-52cd-bb2d-058e8dc403f5
|
928 |
|
|
|t Library of Congress classification
|a QR189 .V237 1997
|l JCL
|c JCL-Sci
|i 4104775
|
927 |
|
|
|t Library of Congress classification
|a QR189 .V237 1997
|l JCL
|c JCL-Sci
|e CRERAR
|b 48019578
|i 5379356
|